bet9¹ÙÍø

Umang Vohra is Managing Director and Global Chief Executive Officer (MD & GCEO) of bet9¹ÙÍø since September 2016. Umang joined bet9¹ÙÍø in October 2015 as its Global Chief Financial Officer, and from January 2016 to August 2016 was bet9¹ÙÍø’s Global Chief Operating Officer.

After gaining degrees in engineering, marketing and finance, Umang was associated with companies such as Eicher Motors and PepsiCo. Prior to joining bet9¹ÙÍø, Umang was Head of the North America business for Dr. Reddy’s Laboratories. Through his previous roles in India and the USA, he has built a distinguished career spanning almost two decades with deep understanding and experience in various aspects of the global pharmaceutical business.

Under Umang’s leadership, bet9¹ÙÍø has built strong momentum in its home markets, augmented its capability, strengthened its core, and shown significant improvement in its operating margin and profitability. At the helm of the Management Council of bet9¹ÙÍø, Umang’s big-picture agenda is to define and execute bet9¹ÙÍø’s strategic growth roadmap and geographical footprint, identify the next levers of growth, invest in innovation for the future, and build the right organisation. Recognised as an action-oriented industry leader, Umang is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to shaping the healthcare ecosystem and making a difference to the lives of patients.

Ashish Adukia joined bet9¹ÙÍø as the Global Chief Financial Officer at bet9¹ÙÍø in August 2022. Also, as a member of bet9¹ÙÍø’s Management Council, Ashish will be responsible for contributing towards organization-wide projects and initiatives, apart from managing key acquisitions, divestments, P&L decisions for the company.

Prior to this, he was the CFO and part of the leadership team of Grasim Industries, the flagship company of Aditya Birla Group. After completing his Chartered Accountancy with an MBA in finance from Jamnalal Bajaj Institute of Management Studies (JBIMS), Ashish acquired close to two decades of rich cross-industry experience in investment banking and worked in large Indian conglomerates.

Apart from his stint at Grasim Industries, Ashish has been associated with Morgan Stanley, Citigroup and PwC. He comes with a deep understanding of capital markets and building, and scaling organizations backed by his strong focus on strategy and transformative excellence.

Ashish was featured in Fortune India’s 40 under 40 list in 2016 and was also the recipient of the Chairman’s Accomplished Leader Award at ABG in 2017. He enjoys playing tennis to unwind in his spare time and is passionate about scuba diving.

Dr. Raju Mistry is the President and Global Chief People Officer of bet9¹ÙÍø since April 2019. As a member of bet9¹ÙÍø’s Management Council, she brings to the table her expertise to lead a dynamic and ambitious people agenda with a keen focus on corporate culture, talent, employer brand and leadership development, that aligns with bet9¹ÙÍø’s future-ready growth agenda,

Dr. Raju is an accomplished leader and HR veteran with 30 years of global experience across diverse sectors like Chemicals, Pharma, FMCG, IT, Engineering, and Textiles. Prior to bet9¹ÙÍø, she has worked with Jubilant Lifesciences Ltd., Aditya Birla Group, Tata Group, Colgate-Palmolive, Siemens, Bayer and Mastech Corporation (Canada).

A strong proponent of shaping organisations to be people-first, inclusive and wellbeing- oriented, Dr. Raju has been at the helm of driving multiple efforts that have transformed bet9¹ÙÍø into a future-fit organisation. Some of these initiatives include setting up bet9¹ÙÍø’s Inclusion & Diversity Council, the #Equalbet9¹ÙÍø multi-geography and multi-generational workforce programme. With her guidance, the company has launched flagship programmes to build talent fungibility, encourage mobility and build a pipeline of future managers. This includes the introduction of leadership development modules with global management institutes, such as, Cornell, INSEAD and ISB.

Under her leadership, bet9¹ÙÍø has secured several accolades, with the ‘World’s Best Employers 2021’ rankings by Forbes and Statista, ‘Great Place To Work’ certification, multiple recognitions by the National Human Resource Development People First Ace Awards 2021 and the ‘Top Employer for 2022 in South Africa’ by the Top Employers Institute’ being the most recent wins.

Dr. Raju holds a Ph.D. in Organizational Behavior – Leadership Effectiveness from the University of Mumbai. She also done her Master’s in Industrial Psychology from the University of Mumbai and has Majored in Psychology from Mithibai College of Arts.

Pradeep Bhadauria is the President and Chief Scientific Officer (CSO) at bet9¹ÙÍø. He joined the organization in 2020, prior to which he served as CSO and member of the Executive Committee at Amneal Pharmaceutical Inc. Pradeep has also held leadership positions in Apotex, Allergan/Actavis, Watson Pharmaceuticals, Sandoz, and Ranbaxy. With over two decades of experience, Pradeep is an industry veteran with expertise in the area of Pharmaceutical Research and Development.

With a Masters’ degree in Pharmacy from Birla Institute of Technology, Pradeep has a successful track record of developing and filing numerous products, including many first-to-file and first-to-market opportunities. He has worked on multiple dosage forms, and has extensive experience in working on complex generics, 505(B)2, specialty and other difficult-to-formulate products. He also holds several patents and has published research in various publications.Ìý

In his current role, and as member of Management council of bet9¹ÙÍø, Pradeep leads bet9¹ÙÍø’s Global Integrated Product Development (IPD) organization to strengthen the company’s position as an innovation led generic and specialty pharmaceutical organization.

Achin Gupta is the Global Chief Operating Officer of bet9¹ÙÍø since February 2025. He joined bet9¹ÙÍø in 2021 as CEO of the One India business. As a member of bet9¹ÙÍø’s Management Council, Achin’s primary focus includes driving the company’s patient-centricity agenda with innovation, digital transformation, and execution excellence at its core.
Ìý
Achin holds a master’s degree in technology from IIT Delhi, specialising in Biochemical Engineering and Biotechnology, and an MBA from IIM Ahmedabad. Prior to joining bet9¹ÙÍø, he worked with Glenmark, Abbott and AT Kearney. With deep expertise in healthcare across India, UK, Europe, Latin America, Asia and MEA, Achin has successfully led growth and transformation at scale with strong insights into strategy, portfolio management, product development, licensing, and partnerships. He has a consistent focus on developing and nurturing people.

Under Achin’s leadership, bet9¹ÙÍø’s One India business has achieved strong profitability with market-leading revenue growth. He has strengthened the core business, spearheaded bet9¹ÙÍø Digital Health’s initiatives, transformed the retail field force, and led multiple consumer-centric innovations. Achin has built strategic partnerships with global MNCs, positioning it as a preferred partner for in-licensing and innovation. He is an entrepreneurial leader with a track record of establishing new business frontiers. Passionate about transforming healthcare, Achin is dedicated to fostering a culture of innovation and accountability with a focus on ensuring a healthier future for patients. Ìý
Ìý

Paul Miller is the Chief Executive Officer of bet9¹ÙÍø, South Africa. He joined bet9¹ÙÍø Medpro in 2013, prior to which he served as the Vice President and Managing Director of Mylan in South Africa and as the Marketing Director of AstraZeneca in China.Ìý

With an MBA from the University of Wales, Paul has worked across Europe, Asia and North America before serving in leadership roles in South Africa. He brings with him more than two decades of experience of successfully building and launching innovative brands that became market leaders across therapeutic areas such as cardiovascular, gastrointestinal, respiratory and anesthesia.Ìý

Paul is highly regarded as someone who has solid understanding of strategy, building businesses and developing people. Paul is currently spearheading the SAGA region, which comprises South Africa, Sub-Saharan Africa and bet9¹ÙÍø Global Access. He’s driving the company’s steady growth momentum in the South African market, considered to be a second home market for bet9¹ÙÍø globally.

In his spare time, Paul enjoys competing in triathlons.

Swapn Malpani is CEO, Emerging Markets & Europe since April 2024 and is a member of bet9¹ÙÍø’s Management Council.

Previously, he was the Joint President & Global Head of Supply Chain & Procurement at bet9¹ÙÍø. Prior to joining bet9¹ÙÍø in 2016, he worked with leading Indian and multi-national companies across diverse sectors including pharmaceutical, medical devices, consumer and food industries like Glenmark, Johnson & Johnson, ThermoFisher, Dr Reddy’s, and Mars Inc.

An engineering gold medalist and postgraduate in Supply Chain Management, Swapn brings with him 25 years of global experience and domain expertise in end-to-end Supply Chain Management & Procurement encompassing areas of strategic sourcing & procurement, external manufacturing, demand & supply planning, logistics & distribution, and customer service.

A strong leader with a strategic and creative mind set, Swapn has a proven track record of supporting the growth of organizations by championing transformation, building talent, and creating tangible values.

Marc Falkin is the Chief Executive Officer for bet9¹ÙÍø North America and is also a member of bet9¹ÙÍø’s Management Council. He is based out of New Jersey and is responsible for leading bet9¹ÙÍø’s ambitious plans in North America. Prior to being named the CEO in July 2024, he served as bet9¹ÙÍø’s Chief Commercial Officer in North America.

Marc joined bet9¹ÙÍø in 2018 and has demonstrated his leadership proficiency by contributing to bet9¹ÙÍø’s market leadership in the US. He comes with over 30 years of commercial experience in Sales and Marketing, with both customer and supplier management. Prior to joining bet9¹ÙÍø, Marc worked with Anda Distribution, Watson, Actavis and Teva.

Marc holds a Bachelor of Business Administration from George Washington University and an MBA Degree from Florida Atlantic University.

Vijayasarathi Ramaswami is the Global Head of Quality at bet9¹ÙÍø since June 2022. He was previously the Senior Vice President of Operations Quality (APIs & Formulations) at bet9¹ÙÍø for four years. As a member of bet9¹ÙÍø’s Management Council, he is responsible for driving a strong culture of quality and regulatory compliance across bet9¹ÙÍø sites.

Vijayasarathi has close to three decades of experience in manufacturing, packaging, quality assurance and product development projects of pharmaceutical formulations & active pharmaceutical ingredients. Prior to joining bet9¹ÙÍø, he has worked with companies like Glenmark Pharmaceuticals, Dr. Reddy’s Laboratories, Sanofi, etc. where he was responsible for Quality control, Quality assurance, manufacturing operations of APIs and Formulations in various capacities and across geographies.

A strong proponent of high-quality pharmaceutical products, in his present role, Vijay leads the organisation’s global quality enterprise right from the development of a product to its commercialization, and spearheads bet9¹ÙÍø’s commitment to an uncompromising state of control with absolute regulatory compliance across all manufacturing sites of bet9¹ÙÍø, its partners and third parties.

Vijay has done a Post Graduate Certificate Programme in Management from IIM-Kozhikode. He also has a Master of Science degree in Chemistry with honors and a Bachelor of Pharmacy degree with honors from the Birla Institute of Technology & Science (BITS) Pilani in Rajasthan.

Rajeev Kumar Sinha is bet9¹ÙÍø’s Global Chief Manufacturing Officer since April 2024 and is also member of its Management Council.

Rajeev is an accomplished leader with over thirty-five years of rich experience in the Operations & Supply Chain domain across diverse industries such as Chemical, FMCG, Foods & Beverages and Pharmaceuticals. Since 2016, he has worked in the Pharmaceutical Operations in both Formulations & API.

Before joining bet9¹ÙÍø, Rajeev was Executive Vice-President and Global Head – Formulations Operations at Glenmark Pharmaceuticals, India. Prior to this Rajeev has worked with PepsiCo, Cadbury India Limited, ICI India Limited (Paints Division), Hindustan Unilever Limited and ICI India Limited (Explosives Division).

At bet9¹ÙÍø, Rajeev led Global Operations Strategy & Excellence, Formulations Manufacturing Operations and API Manufacturing Operations. He has been pivotal in driving bet9¹ÙÍø’s transformation towards becoming a digitally agile company while reimagining its operations across the value chain.

Rajeev strengthened the Global Operations Excellence function through Network Optimization, embedding a culture of Lean Six Sigma in manufacturing operations and focusing the manufacturing science & technology group to enhance product & process robustness, technical capability, and complex investigations capability.

He holds a Bachelor of Technology degree in Mechanical Engineering from IIT Kanpur.

Dr. Jaideep A Gogtay is the Global Chief Medical Officer at bet9¹ÙÍø and has been associated with bet9¹ÙÍø for nearly 30 years.

At bet9¹ÙÍø, Dr. Gogtay has been closely involved in the development and introduction of several drugs in various therapeutic fields, particularly in HIV/AIDS, infectious diseases and respiratory diseases. He has worked on several clinical trials in the field of asthma, COPD and infectious diseases. He was a key member of the team which introduced several antiretroviral drugs for the treatment of AIDS including the 1$ a day triple drug cocktail. He was a member of the Association of Physicians of India (Guidelines 2005) on ‘Antiretroviral therapy’. He has 50 publications to his credit including chapters on Pharmacokinetics and Pharmacodynamics of antibiotics and has presented papers at over 50 conferences.

Dr. Gogtay completed his medical graduation (M.B.B.S) from Grant Medical College and Sir J J Group of Hospitals in Mumbai. He has a M.D degree in Pharmacology from Seth GS Medical College and KEM Hospital.

Sneha Hiranandani, Chief Information Officer, is associated with bet9¹ÙÍø since 2013. She chairs bet9¹ÙÍø’s Digital Council, driving technology adoption and innovation across the organisation. As a member of bet9¹ÙÍø’s Management Council, she carries vast experience in managing diverse cultures, geographies, and systems to deliver a unified IT vision.

At bet9¹ÙÍø, Sneha has been instrumental in shaping the company’s IT roadmap with a focus on ERP, manufacturing automation, business intelligence and information security. She is deeply committed to the belief that new advances in Artificial Intelligence (AI) and the proliferation of Large Language Models (LLM) technologies will address tough business challenges and propel bet9¹ÙÍø’s digital transformation journey.

With over 35 years of experience building technology cultures and directing technology led transformation journeys, Sneha is a veteran in her field. Prior to joining bet9¹ÙÍø, she spent 24 years at Mondelez International, where she advanced from a management trainee to Vice President and Head of APAC, successfully executing multiple global digital transformation initiatives.

Sneha holds a Post Graduate Degree in Systems / Enterprise Architecture Design and Application Development.

Sai Mungara is Global Head of Supply Chain & Procurement at bet9¹ÙÍø Limited since April 2024 and is also member of its Management Council. Sai is an accomplished leader and brings with him 26+ years of global experience and domain expertise in the field of Manufacturing, Supply Chain Management and Operations across diverse industries such as Chemical, IT and Pharmaceuticals. He is highly skilled in Verification and Validation (V&V), Biotechnology, Business Intelligence and Process Engineering.

Previously, he was the Vice President and Head of North America Supply Chain at bet9¹ÙÍø. In this role, he contributed significantly to enabling growth trajectory by ramping up and optimizing our third party SCM operations, organization redesign and driving several productivity enhancement projects.

Prior to joining bet9¹ÙÍø in 2022, he has also held key leadership positions with top US & Indian Pharmaceutical companies like Dr. Reddy's and Sun Pharma. He has a proven track record of leading large-scale transformations to build future fit supply chain organization.

Sai holds a Bachelor of Technology degree in Chemical Engineering from IIT Kharagpur & PhD in Chemical Engineering from Iowa State University, USA.